# Tangen Biosciences, Inc.

Canonical: https://abierto.us/vendors/tangen-biosciences-inc-k3d1v93lh4f8

- UEI: K3D1V93LH4F8
- CAGE: 6ZYQ1
- Location: Branford, CT
- Awards in window: 2 (2 transactions), -$296,500 obligated, May 30, 2024 to September 30, 2025

## Awarding agencies

- Office of Assistant Secretary for Preparedness and Response: 2 awards, -$296,500

## Industries

- 541711 Professional, Scientific, and Technical Services: -$500
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): -$296,000

## Competition

- Full and Open Competition: 2 awards

## Largest awards

- HHSO100201700028C (definitive contract): -$500, Barda - Aspr / Daappo / Barda DCMA. The Purpose of This Modification Is to Deobligate Funding in the Amount of $500.00 in Cancelling Funds from Clin 0002. End of Modification.. https://www.usaspending.gov/award/CONT_AWD_HHSO100201700028C_7505_-NONE-_-NONE-/
- 75A50120C00085 (definitive contract): -$296,000, Barda - Aspr / Daappo / Barda DCMA. Tangen Sars-Cov-2 Assay - Nce to Allow Time for the Eua to Move Through FDA Approval.. https://www.usaspending.gov/award/CONT_AWD_75A50120C00085_7505_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/tangen-biosciences-inc-k3d1v93lh4f8.
